[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@Exclamotite69](/creator/twitter/Exclamotite69) "@DersimSylwan They have a competitive advantage in production of antibodies: they use procaryotes instead of eucaryotes (it's cheaper). They aren't the only ones but it remains an edge. They will launch soon the biosimillar of Lucentis in the USA. Best-case scenario: Hanza becomes a fastgrower"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1947756761382789432) 2025-07-22 20:32:54 UTC XXX followers, XX engagements "Top X holding: - $GMAB Genmab: biotech stalwart/fast grower - $GENT.OL Gentian Diagnostics: medtech fast grower - $CRMD CorMedix: pharma/medtech fast grower - $XBRANE.ST Xbrane Biopharma: biotech turnaround - $AUTL Autolus Therapeutics: biotech fast grower"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1939986492828360718) 2025-07-01 09:56:37 UTC XXX followers, XXX engagements "Too many opportunities in Healthcare it's amazing - Genmab - $GMAB - CorMedix - $CRMD (I added more today at $12.80) - ADMA Biologics - $ADMA (added at $18.20) - Xbrane - $XBRANE.SE : a VERY interesting turnaround case with a HUGE upside (but it could also go to 0)"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1938625492480888962) 2025-06-27 15:48:29 UTC XXX followers, XXX engagements "@ReturnsJourney The current opportunities are not in pure techs but in bio and medtechs This sector is undervalued. Few names: - CorMedix $CRMD - GenMab $GMAB - Xbrane $XBRANE this one is a speculative turnaround"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1938939196015812928) 2025-06-28 12:35:02 UTC XXX followers, XXX engagements "@Quality_stocksA $GOOGL (I own this stock) and $TSLA (I love this company)"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1946971626739773887) 2025-07-20 16:33:03 UTC XXX followers, XXX engagements "@equitybaron Thanks this one is in the PF of William Higgons the French Buffett. I own $RES.MI (Recupero Etico Sostenibile) a beautifull familial company operating in waste recycling. A perfect Lynch stock completly under the radar"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1946160498992353721) 2025-07-18 10:49:55 UTC XXX followers, XX engagements "@Sh24363159 Certainly but some many pumps&dumps on Stocktwits that's crazy"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1948301566277984680) 2025-07-24 08:37:45 UTC XXX followers, XX engagements "@grok @pkp92 @mvcinvesting @grok Will $GOOGL be a threat for $NBIS after they announced to increase their CAPEX yesterday"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1948384466470162852) 2025-07-24 14:07:10 UTC XXX followers, XXX engagements "@investseekers Wonderful Gem-mab So undervalued"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1945768192929878432) 2025-07-17 08:51:02 UTC XXX followers, XX engagements "@KyleAdamsStocks 1) $GMAB Genmab 2) $GENT.OL Gentian Diagnostics 3) $CRMD CorMedix 4) $DCTH Delcath Systems 5) $AUTL Autolus Therapeutics"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1931120489683915154) 2025-06-06 22:46:17 UTC XXX followers, XXX engagements "@investseekers It was an overreaction of the market. It was just an early candidate in the pipeline not a big deal. I liked that the management decided to stop development. Genmab's capital allocation is impressive and Epkinly+Rina-S are best-in-class products"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1934999313127534675) 2025-06-17 15:39:21 UTC XXX followers, XXX engagements "@ReturnsJourney . and if these X candidates failed to be successfull Genmab would have enough cash to imediatly buy another advanced candidate. And maybe another one in X or X years. At the current price we only buy the commercialized drugs and we get the pipeline for free"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1941814677152956578) 2025-07-06 11:01:10 UTC XXX followers, XX engagements "@gatorbait2022 $GOOGL will be a threat for $NBIS"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1948383731120550185) 2025-07-24 14:04:15 UTC XXX followers, XXX engagements "New buys in June: - $XBRANE.ST - $MIND Mind Technology: Oil&Gas provider late turnaround - $RES.MI Recupero Etico Sostenibile: industrial micro-stalwart/fast grower - $ADMA ADMA Biologics: biotech fast grower"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1939988486146195460) 2025-07-01 10:04:32 UTC XXX followers, XXX engagements "@ReturnsJourney Its main drug (Darzalex 2/3 of the sales but the proportion is decreasing due to the launch of new products) will lose its patent around 2029. Other pharmas have the same issue. I am confident in Genmab to find new growth drivers. There are X drugs in its advanced pipeline"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1941813742464840135) 2025-07-06 10:57:28 UTC XXX followers, XXX engagements "@DersimSylwan It's a turnaround. They were near to bankruptcy few months ago. They successfully divested some activities and then raised capital recently. Now they don't have any debt and a good runway. They hope to breakeven in the next quarters"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1947755996165677525) 2025-07-22 20:29:51 UTC XXX followers, XX engagements "Day Trading for fun: I sold my position in $TPG.DE (The Platform Group only XXXX% of my PF) to buy a few shares of $GMAB (Genmab). J&J will publish Darzalex sales today ($GMAB earns around XX% royalties from this one) and I expect it will be a catalyst to propel the SP of $GMAB"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1945428871362257282) 2025-07-16 10:22:41 UTC XXX followers, XXX engagements "@Ridingwaves69 It seems undervalued like $GMAB (Genmab)"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1940827726342246832) 2025-07-03 17:39:23 UTC XXX followers, XX engagements "@stockjockey4 No manipulation just a reaction of fear after $GOOGL earnings call. They will be a threat for Nebius"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1948384032032432550) 2025-07-24 14:05:27 UTC XXX followers, XXX engagements "@KiaraKeira96188 Hi what could be the impact of this news"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1942187866806694344) 2025-07-07 11:44:06 UTC XXX followers, XX engagements "Current Portfolio. Top 5: - $CRMD CorMedix - $GMAB Genmab - $GENT.OL Gentian Diagnostics - $XBRANE.ST Xbrane Biopharma - $ALDOC.PA Omer-Degugis et Cie"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1942347837624258912) 2025-07-07 22:19:46 UTC XXX followers, 2148 engagements "@meeijer Not the best upside but $SIGA is an assymetric bet. Phama company selling a drug against spox/mpox to the governments (prevention of bioterrorism). Contract with BARDA to be renewed in 2025: - if huge contract: x-bagger; - if not: still a cheap cow cash high-dividend yield (8%)"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1947639054868107664) 2025-07-22 12:45:10 UTC XXX followers, XXX engagements "@meeijer I own $GOOGL but I just expect an increase of the PER from XX to XX and a CAGR of the EPS of 10%"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1947072946037543082) 2025-07-20 23:15:39 UTC XXX followers, XX engagements "@Mufasa_Capital Interesting thank you. Take a look at $SWP.PA (Sword) another serial acquirer in the sector with good results and balance sheet as well"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1948306820209975706) 2025-07-24 08:58:38 UTC XXX followers, XX engagements "@salins99 @shantaram83 $CRMD CorMedix $GMAB Genmab $DCTH Delcath (not in my PF) $SIGA Siga (hedge in case of war) $COV.V Covalon $HANZA.OL Hanza (very intersting turnaround under the radar) $GENT.OL Gentian Diagnostics"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1944533052945822030) 2025-07-13 23:03:02 UTC XXX followers, XXX engagements "@taobanker $CPRX reminds me Genmab but with a better long term trend Thanks"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1940825736333742329) 2025-07-03 17:31:28 UTC XXX followers, XXX engagements "@maxwellhouse99 $CRMD CorMedix $GMAB Genmab $SIGA Siga"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1947457079415083047) 2025-07-22 00:42:04 UTC XXX followers, XXX engagements "The valuation of Genmab ($GMAB) is insane Very good entry point"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1938224473121095912) 2025-06-26 13:14:59 UTC XXX followers, XXX engagements "$GMAB I'm not a big fan of technical analysis but it's the only way to explain Genmab's dip after a series of positive news releases. It seems there is a good entry point. It's undervalued. By far"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1937555373935690012) 2025-06-24 16:56:13 UTC XXX followers, XXX engagements "Current PF. Top 5: - $GMAB Genmab - $CRMD CorMedix - $GENT.OL Gentian Diagnostics - $RES.MI Recupero Etico Sostenibile - $XBRANE.ST Xbrane Biopharma"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1943830242365169925) 2025-07-12 00:30:19 UTC XXX followers, XXX engagements "That's exactly what $GMAB (Genmab) is doing. I love this management"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1942350371952726160) 2025-07-07 22:29:50 UTC XXX followers, XXX engagements "@meeijer $XXX for $TMDX seems very high all the future growth is already priced $250-$300 would be more realistic"  [@Exclamotite69](/creator/x/Exclamotite69) on [X](/post/tweet/1947072476451598404) 2025-07-20 23:13:47 UTC XXX followers, 1105 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Exclamotite69
"@DersimSylwan They have a competitive advantage in production of antibodies: they use procaryotes instead of eucaryotes (it's cheaper). They aren't the only ones but it remains an edge. They will launch soon the biosimillar of Lucentis in the USA. Best-case scenario: Hanza becomes a fastgrower" @Exclamotite69 on X 2025-07-22 20:32:54 UTC XXX followers, XX engagements
"Top X holding: - $GMAB Genmab: biotech stalwart/fast grower - $GENT.OL Gentian Diagnostics: medtech fast grower - $CRMD CorMedix: pharma/medtech fast grower - $XBRANE.ST Xbrane Biopharma: biotech turnaround - $AUTL Autolus Therapeutics: biotech fast grower" @Exclamotite69 on X 2025-07-01 09:56:37 UTC XXX followers, XXX engagements
"Too many opportunities in Healthcare it's amazing - Genmab - $GMAB - CorMedix - $CRMD (I added more today at $12.80) - ADMA Biologics - $ADMA (added at $18.20) - Xbrane - $XBRANE.SE : a VERY interesting turnaround case with a HUGE upside (but it could also go to 0)" @Exclamotite69 on X 2025-06-27 15:48:29 UTC XXX followers, XXX engagements
"@ReturnsJourney The current opportunities are not in pure techs but in bio and medtechs This sector is undervalued. Few names: - CorMedix $CRMD - GenMab $GMAB - Xbrane $XBRANE this one is a speculative turnaround" @Exclamotite69 on X 2025-06-28 12:35:02 UTC XXX followers, XXX engagements
"@Quality_stocksA $GOOGL (I own this stock) and $TSLA (I love this company)" @Exclamotite69 on X 2025-07-20 16:33:03 UTC XXX followers, XXX engagements
"@equitybaron Thanks this one is in the PF of William Higgons the French Buffett. I own $RES.MI (Recupero Etico Sostenibile) a beautifull familial company operating in waste recycling. A perfect Lynch stock completly under the radar" @Exclamotite69 on X 2025-07-18 10:49:55 UTC XXX followers, XX engagements
"@Sh24363159 Certainly but some many pumps&dumps on Stocktwits that's crazy" @Exclamotite69 on X 2025-07-24 08:37:45 UTC XXX followers, XX engagements
"@grok @pkp92 @mvcinvesting @grok Will $GOOGL be a threat for $NBIS after they announced to increase their CAPEX yesterday" @Exclamotite69 on X 2025-07-24 14:07:10 UTC XXX followers, XXX engagements
"@investseekers Wonderful Gem-mab So undervalued" @Exclamotite69 on X 2025-07-17 08:51:02 UTC XXX followers, XX engagements
"@KyleAdamsStocks 1) $GMAB Genmab 2) $GENT.OL Gentian Diagnostics 3) $CRMD CorMedix 4) $DCTH Delcath Systems 5) $AUTL Autolus Therapeutics" @Exclamotite69 on X 2025-06-06 22:46:17 UTC XXX followers, XXX engagements
"@investseekers It was an overreaction of the market. It was just an early candidate in the pipeline not a big deal. I liked that the management decided to stop development. Genmab's capital allocation is impressive and Epkinly+Rina-S are best-in-class products" @Exclamotite69 on X 2025-06-17 15:39:21 UTC XXX followers, XXX engagements
"@ReturnsJourney . and if these X candidates failed to be successfull Genmab would have enough cash to imediatly buy another advanced candidate. And maybe another one in X or X years. At the current price we only buy the commercialized drugs and we get the pipeline for free" @Exclamotite69 on X 2025-07-06 11:01:10 UTC XXX followers, XX engagements
"@gatorbait2022 $GOOGL will be a threat for $NBIS" @Exclamotite69 on X 2025-07-24 14:04:15 UTC XXX followers, XXX engagements
"New buys in June: - $XBRANE.ST - $MIND Mind Technology: Oil&Gas provider late turnaround - $RES.MI Recupero Etico Sostenibile: industrial micro-stalwart/fast grower - $ADMA ADMA Biologics: biotech fast grower" @Exclamotite69 on X 2025-07-01 10:04:32 UTC XXX followers, XXX engagements
"@ReturnsJourney Its main drug (Darzalex 2/3 of the sales but the proportion is decreasing due to the launch of new products) will lose its patent around 2029. Other pharmas have the same issue. I am confident in Genmab to find new growth drivers. There are X drugs in its advanced pipeline" @Exclamotite69 on X 2025-07-06 10:57:28 UTC XXX followers, XXX engagements
"@DersimSylwan It's a turnaround. They were near to bankruptcy few months ago. They successfully divested some activities and then raised capital recently. Now they don't have any debt and a good runway. They hope to breakeven in the next quarters" @Exclamotite69 on X 2025-07-22 20:29:51 UTC XXX followers, XX engagements
"Day Trading for fun: I sold my position in $TPG.DE (The Platform Group only XXXX% of my PF) to buy a few shares of $GMAB (Genmab). J&J will publish Darzalex sales today ($GMAB earns around XX% royalties from this one) and I expect it will be a catalyst to propel the SP of $GMAB" @Exclamotite69 on X 2025-07-16 10:22:41 UTC XXX followers, XXX engagements
"@Ridingwaves69 It seems undervalued like $GMAB (Genmab)" @Exclamotite69 on X 2025-07-03 17:39:23 UTC XXX followers, XX engagements
"@stockjockey4 No manipulation just a reaction of fear after $GOOGL earnings call. They will be a threat for Nebius" @Exclamotite69 on X 2025-07-24 14:05:27 UTC XXX followers, XXX engagements
"@KiaraKeira96188 Hi what could be the impact of this news" @Exclamotite69 on X 2025-07-07 11:44:06 UTC XXX followers, XX engagements
"Current Portfolio. Top 5: - $CRMD CorMedix - $GMAB Genmab - $GENT.OL Gentian Diagnostics - $XBRANE.ST Xbrane Biopharma - $ALDOC.PA Omer-Degugis et Cie" @Exclamotite69 on X 2025-07-07 22:19:46 UTC XXX followers, 2148 engagements
"@meeijer Not the best upside but $SIGA is an assymetric bet. Phama company selling a drug against spox/mpox to the governments (prevention of bioterrorism). Contract with BARDA to be renewed in 2025: - if huge contract: x-bagger; - if not: still a cheap cow cash high-dividend yield (8%)" @Exclamotite69 on X 2025-07-22 12:45:10 UTC XXX followers, XXX engagements
"@meeijer I own $GOOGL but I just expect an increase of the PER from XX to XX and a CAGR of the EPS of 10%" @Exclamotite69 on X 2025-07-20 23:15:39 UTC XXX followers, XX engagements
"@Mufasa_Capital Interesting thank you. Take a look at $SWP.PA (Sword) another serial acquirer in the sector with good results and balance sheet as well" @Exclamotite69 on X 2025-07-24 08:58:38 UTC XXX followers, XX engagements
"@salins99 @shantaram83 $CRMD CorMedix $GMAB Genmab $DCTH Delcath (not in my PF) $SIGA Siga (hedge in case of war) $COV.V Covalon $HANZA.OL Hanza (very intersting turnaround under the radar) $GENT.OL Gentian Diagnostics" @Exclamotite69 on X 2025-07-13 23:03:02 UTC XXX followers, XXX engagements
"@taobanker $CPRX reminds me Genmab but with a better long term trend Thanks" @Exclamotite69 on X 2025-07-03 17:31:28 UTC XXX followers, XXX engagements
"@maxwellhouse99 $CRMD CorMedix $GMAB Genmab $SIGA Siga" @Exclamotite69 on X 2025-07-22 00:42:04 UTC XXX followers, XXX engagements
"The valuation of Genmab ($GMAB) is insane Very good entry point" @Exclamotite69 on X 2025-06-26 13:14:59 UTC XXX followers, XXX engagements
"$GMAB I'm not a big fan of technical analysis but it's the only way to explain Genmab's dip after a series of positive news releases. It seems there is a good entry point. It's undervalued. By far" @Exclamotite69 on X 2025-06-24 16:56:13 UTC XXX followers, XXX engagements
"Current PF. Top 5: - $GMAB Genmab - $CRMD CorMedix - $GENT.OL Gentian Diagnostics - $RES.MI Recupero Etico Sostenibile - $XBRANE.ST Xbrane Biopharma" @Exclamotite69 on X 2025-07-12 00:30:19 UTC XXX followers, XXX engagements
"That's exactly what $GMAB (Genmab) is doing. I love this management" @Exclamotite69 on X 2025-07-07 22:29:50 UTC XXX followers, XXX engagements
"@meeijer $XXX for $TMDX seems very high all the future growth is already priced $250-$300 would be more realistic" @Exclamotite69 on X 2025-07-20 23:13:47 UTC XXX followers, 1105 engagements
/creator/twitter::1763671676901015552/posts